Latest / The National Briefing

In a landmark development for South Africa’s fight against HIV, the South African Health Products Regulatory Authority (SAHPRA) has officially registered Lenacapavir, a long-acting injectable medicine designed to prevent HIV infection
In a landmark development for South Africa’s fight against HIV, the South African Health Products Regulatory Authority (SAHPRA) has officially registered Lenacapavir, a long-acting injectable medicine designed to prevent HIV infection.
Guest: Aaron Motsoaledi: Minister for Health
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.